Targeting monocytic Occludin impairs transendothelial migration and HIV neuroinvasion.
Diana BrychkaNilda Vanesa Ayala-NunezAmandine DupasYonis BareEmma PartiotVincent MittelheisserVincent LucanskyJacky G GoetzNaël OsmaniRaphaël GaudinPublished in: EMBO reports (2024)
Transmigration of circulating monocytes from the bloodstream to tissues represents an early hallmark of inflammation. This process plays a pivotal role during viral neuroinvasion, encephalitis, and HIV-associated neurocognitive disorders. How monocytes locally unzip endothelial tight junction-associated proteins (TJAPs), without perturbing impermeability, to reach the central nervous system remains poorly understood. Here, we show that human circulating monocytes express the TJAP Occludin (OCLN) to promote transmigration through endothelial cells. We found that human monocytic OCLN (hmOCLN) clusters at monocyte-endothelium interface, while modulation of hmOCLN expression significantly impacts monocyte transmigration. Furthermore, we designed OCLN-derived peptides targeting its extracellular loops (EL) and show that transmigration of treated monocytes is inhibited in vitro and in zebrafish embryos, while preserving vascular integrity. Monocyte transmigration toward the brain is an important process for HIV neuroinvasion and we found that the OCLN-derived peptides significantly inhibit HIV dissemination to cerebral organoids. In conclusion, our study identifies an important role for monocytic OCLN during transmigration and provides a proof-of-concept for the development of mitigation strategies to prevent monocyte infiltration and viral neuroinvasion.
Keyphrases
- endothelial cells
- dendritic cells
- antiretroviral therapy
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- peripheral blood
- men who have sex with men
- hiv aids
- hepatitis c virus
- high glucose
- vascular endothelial growth factor
- sars cov
- gene expression
- oxidative stress
- south africa
- blood brain barrier
- induced pluripotent stem cells
- climate change
- poor prognosis
- cancer therapy
- drug delivery
- cerebral ischemia
- white matter
- subarachnoid hemorrhage
- amino acid
- multidrug resistant
- brain injury
- cerebrospinal fluid